
Andrew Mebane Southerland
MD, MSc, FAHA
Medicine
Neurology, Internal Medicine
Charlottesville, Virginia, United States
Executive Vice Chair, Associate Professor
Andrew Mebane Southerland, MD, MSc, FAHA is an associate professor in the division of vascular neurology, departments of neurology and public health sciences at the University of Virginia Health. Dr. Southerland currently serves as the executive vice-chair in the UVA department of neurology.
Dr. Southerland received his M.D. from the Brody School of Medicine at East Carolina University as a prestigious Brody Scholar. As a medical student, he won multiple academic awards, including the AAN Medical Student Prize for Excellence in Neurology and induction into the Alpha Omega Alpha honor society. Dr. Southerland completed his internship at Carolinas Medical Center, where he was named the Arnold R. Frazier Intern of the Year. He then completed his neurology residency at the University of Virginia, where he also served as chief resident. During his vascular neurology fellowship at UVA, Dr. Southerland completed a master of science degree in clinical research with UVA's department of public health sciences. As a faculty clinician, Dr. Southerland has received numerous accolades for teaching and clinical excellence, including a 2017 Bedside Manner Award from OurHealth Magazine.
Dr. Southerland is the past recipient of an early career award from the American Heart Association/American Stroke Association (AHA/ASA) National Clinical Research Program and currently serves on the AHA/ASA Telestroke Committee and the American Academy of Neurology Education Committee. Dr. Southerland also participated on the writing committee for the 2018 AHA/ASA Updated Guideline on the Management of Acute Ischemic Stroke. He serves as the principal investigator or co-investigator for numerous stroke clinical trials. His primary research interests focus on innovative methods of prehospital stroke care, novel applications of telemedicine and telestroke, and gene-by-environment associations in non-atherosclerotic vasculopathies, such as cervical artery dissection and fibromuscular dysplasia.